{Excerpt} Overall Global Risk Statement -- This global rapid risk assessment (RRA) aims to assess the current public health risk associated with the 2024 upsurge of mpox in in Africa , in the context of the continuing global reporting of mpox cases in other regions since 2022, with a focus on updates since the previous RRA in September 2025. Global overview -- As of 28 January 2026, the monkeypox virus (MPXV) continues to spread globally, causing both localized and extended mpox outbreaks driven by various MPXV clades (Ia, Ib, IIa, and IIb) in diverse settings. -- Furthermore, recombination of MPXV clades has been documented, with two cases of a recombinant clade Ib/IIb MPXV strain reported in recent months. -- Globally, from 1 January 2022 to 31 December 2025 (latest global data available), 143 countries and territories across all WHO regions have reported 177 848 confirmed cases, including 477 deaths (case fatality ratio ...
Zoonotic #Influenza #Preparedness: Dutch Medical #Labs Efficiently Detect Animal Influenza A Viruses - External #Quality #Assessment, 2023
Highlights • Concern over H5N1 bird flu testing and detection in the Netherlands is increasing. • 50 human laboratories in the Netherlands, Aruba, Bonaire , and Curacao were assessed. • The laboratories detected animal influenza viruses with high performance. • Few laboratories identified the animal subtype of detected influenza A viruses. • National reference laboratory capacity to identify the animal subtype is critical. Abstract Background Since 2022, highly pathogenic H5N1 influenza A virus clade 2.3.4.4b has caused global outbreaks among wild birds and poultry , with increasing mammalian and sporadic human infections . This elevates concerns about zoonotic transmission and pandemic risk , highlighting the need for accurate detection and identification of animal influenza A viruses by human clinical diagnostic laboratories (hCDL). Methods To evaluate routine diagnostic performance , an External Quality Assessment (EQA) panel containing inactivate...